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Abstract We have recently cloned a cDNA for mouse matrilin-
4. By sequence comparison we identified the 12 kb long human
matrilin-4 gene as a part of a high-throughput genomic sequence
(HS453C12) in the databases. Additionally we found a human
matrilin-4 expressed sequence tag (H54037) in the database that
had been mapped to chromosome 20q13.1^2. The gene contains
10 exons and, like the matrilin-1 gene, the human matrilin-4 gene
contains an AT-AC intron between the two exons en coding the
coiled-coil domain. The cDNA sequence of human matrilin-4 was
determined by sequencing of RT-PCR products obtained from
mRNA of the human embryonic kidney cell line HEK 293. At the
amino acid level it showed an overall sequence identity to the
mature mouse matrilin-4 of 91% with a maximum of 97% in the
second vWFA-like module. Alternative splicing leads to three
different mRNAs. They all encode the putative signal peptide, the
two vWFA-like domains and the potential coiled-coil K-helical
oligomerisation domain but differ in that either one, two or three
EGF-like domains are retained in the mature mRNA. Due to a G
to A mutation at the splice donor site of intron C, the third exon
encodes an untranslated pseudo-exon specifying the first EGF-
like domain when compared to mouse matrilin-4.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The matrilin family has to date four members who all share
a structure made up of von Willebrand factor A domains,
epidermal growth factor-like domains and a coiled coil K-hel-
ical module. They accordingly belong to the von Willebrand
factor type A-like domain superfamily that consists of pro-
teins with di¡erent domain organisation and a variety of func-
tions [1].
Matrilin-1 (previously called cartilage matrix protein or
CMP) and matrilin-3 are expressed mainly in cartilage [2^4],
while matrilin-2 and -4 occur in a wide variety of extracellular
matrices [5,6]. Matrilin-1 forms trimers of identical ellipsoid
subunits assembled via their C-terminal extension domains in
a coiled-coil K-helix [7] unit and it has also been shown that
synthetic peptides corresponding to the C-terminal domain of
matrilin-2 assemble into a three-stranded K-helical coiled-coil
[8]. Additionally heterotetramers consisting of two subunits of
matrilin-1 and two of matrilin-3 have recently been described
[9]. Matrilin-1 is tightly associated with cartilage proteogly-
cans [10,11] as well as being a component of both collagen-
dependent [12] and collagen-independent ¢brils [13] and on
the basis of the related structures other matrilins may play
similar roles.
The primary structure of matrilin-1 has been deduced from
chicken [14], man [15] and mouse [16] cDNA, of matrilin-2
from mouse and partially from human cDNA [5], of matrilin-
3 from mouse [3], chicken [4] and human cDNA [17] and of
matrilin-4 from mouse cDNA [6]. In all cases the sequence is
highly conserved between species, with the vWFA-like domain
being most conserved and the coiled-coil the least conserved
domain.
Only the gene structures of matrilin-1 for chicken [18], man
[19] and mouse [20] are known and show a similar overall
structure. In all three species the codon phases of the introns
are conserved and the splice sites show evolutionarily well
preserved nucleotide sequences [20]. In the chicken matrilin-
1 gene the existence of the minor class of AT-AC introns was
shown for the ¢rst time [18]. The unusual intron is conserved
in the matrilin-1 genes of man and mouse and it is now well
accepted that these introns are spliced by the minor subclass
of U12-type spliceosomes [21]
Here we report on the organisation of the human matrilin-4
gene and the primary structure of human matrilin-4.
2. Materials and methods
2.1. RNA preparation, RT-PCR and genomic PCR
Total RNA from the lung of a 65-year-old female undergoing lung
surgery was prepared by the guanidinium isothiocyanate method.
Poly(A) RNA was prepared from the total lung RNA and directly
from HEK 293 cells and WI-26 human ¢broblasts with the QuickPrep
Micro mRNA Puri¢cation kit (Pharmacia). Human placenta Poly-
(A) RNA was taken from the Marathon cDNA Ampli¢cation kit
(Clontech). Reverse transcription using an oligo dT primer was car-
ried out with Superscript II (BRL), the following PCR was carried out
with Amplitaq (Perkin Elmer) on two overlapping fragments using
primers h41 or h420 and h421 for the N-terminal and h414 and
h423 for the C-terminal fragments. PCR conditions after an initial
incubation at 94‡C for 3 min were 40 cycles 1 min 94‡C, 1 min
Tm35‡C (4+2 rule), 1 min 72‡C with the standard protocol and addi-
tional 10% DMSO.
Genomic PCR was performed with 100 ng human or mouse ge-
nomic DNA per reaction using the Expand High Fidelity PCR system
(Boehringer Mannheim) following the manufacturer’s recommenda-
tions.
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Oligonucleotides used for human matrilin-4 were: h425 5P-GTTG-
CCAGCACCAATGTGTCAATG-3P (nt 76^99); h426 5P-CAAACA-
GCTCTTGTTATCTGCTGC-3P (nt 144^167). The numbering of the
nucleotides is according to Fig. 2. h41 5P-ACACCTCCATTCTCTGT-
CC-3P (nt 1^19); h420 5P-ATGAGAGGCCTTCTTTGCTGGCCCG-
3P (nt 29^53); h414 5P-GCTTTGTACTCCAGCAGGAC-3P (nt 759^
778); h421 5P-CCTCGCTCACACACTGGAACTC-3P (nt 974^953);
h423 5P-ATCCAACAAAGAACTGAGCGCAG-3P (nt 2048^2026).
The numbering of the nucleotides is according to Fig. 3. Oligonucleo-
tides used for mouse matrilin-4 were: m42 5P-AGTCCTTCGATCT-
CATCC-3P (nt 685^702); m414 5P-CATTCTACTGCGCCTGCAAC-
TC-3P (nt 802^823); m416 5P-GCCAAACAATTCTTGTTATCTG-3P
(nt 862^841); m415 5P-CGACAGAAATACGAGTCCACGGAG-3P
(nt 937^914). The numbering of the nucleotides is according to [6].
2.2. DNA sequencing
DNA sequencing was performed on PCR products using the ABI
Prism Big Dye Terminator Cycle Sequencing Ready Reaction kit and
the products were resolved on an ABI Prism 377 automated sequencer
(Perkin-Elmer/Applied Biosystems). PCR products were sequenced
directly at least twice in both directions to exclude PCR artifacts.
Nucleotide sequence analysis was performed with the programs of
the GCG package [22].
3. Results
3.1. Human matrilin-4 gene
By screening the databases with the recently determined
mouse matrilin-4 cDNA sequence as a query we identi¢ed
the entire human matrilin-4 gene on a contig of a phase I
HTGS [23] (high-throughput genomic sequence, clone
HS453C12, accession number AL021578). The contig is lo-
cated on chromosome 20 and the gene spans about 12 kb
consisting of at least 10 exons (Fig. 1, Table 1). The putative
existence of another intron in the 5P untranslated region has
to be resolved when the transcription start is determined.
Supposing that no more introns exist, the putative promoter
contains by computer analysis [24] a TATA motif-like se-
quence, TGTAAAT, 75 bases upstream of the translation
start, whereas no characteristic CCAAT box is found. Exons
were identi¢ed by £anking consensus splice signals and by
comparison with the cDNA sequence. The ¢rst exon (E1)
encodes the signal peptide and a short sequence of 8 amino
acid residues N-terminal of the ¢rst vWFA domain. The ¢rst
vWFA domain (E2) and the four EGF-like domains (E3, E4,
E5 and E6) are each encoded by single exons, whereas the
second vWFA domain (E7 and E8) and the coiled-coil do-
main (E9 and E10) are represented by two exons each. With
the exception of the single coding exon for the vWFA1 do-
main the exon-intron organisation of the human matrilin-4
gene shows some similarities to the modular organisation of
the genes for matrilin-1 of man [19], mouse [20] and chicken
[18]. The most interesting common feature is the unusual in-
tron (I) that divides the coiled-coil domain and belongs in the
case of matrilin-1 to a subgroup of introns that are spliced by
the U12-type spliceosome [21]. The 5P consensus splice site
(ATATCCTTT) for U12-type introns is completely conserved
in the human matrilin-4 gene. The intron also contains a
putative branch site (CTCCTTAACCGC) 10 nucleotides up-
stream of the 3P splice site that is highly homologous to the
consensus branch site (TTCCTTRACYCY) of U12-type AT-
AC introns [21].
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Fig. 1. Organisation of the human matrilin-4 gene. Exon-intron organisation of the human gene for matrilin-4 and the assignment of exons to
the structural domains of human matrilin-4. S, signal peptide; A1 and A2, vWFA-like domains; CC, coiled-coil oligomerisation domain. The
pseudo-EGF1 exon 3 and the 3P UTR in exon 10 are represented as open boxes.
Table 1
Splice junction sites of the human matrilin-4 gene derived from HTGS HS453C12
Exon Size (bp) Splice donor Intron Size (bp) Splice acceptor Codon phase Amino acid interrupted
1 73a GACAGgtgaac A 711 ctccccgcagGTC I G (25)
2 570 GTGTGgtgagt B/C 2784 tcttcctcagCCA I A (215)
4 123 CAGGGgtgagc D 96 ctcctgccagCCA I A (256)
5 123 TCAGGgtgagt E 92 ctcctttcagTCC I V (297)
6 123 CAACCgtgagt F 2303 ggctgtgcagGGT I R (338)
7 414 GGAAGgtgggc G 99 ggccttgcagGCA I G (476)
8 153 TCCAGgtgagc H 3887 cggcttgcagAGG I E (527)
9 108 GAACCatatcc I 82 aaccgctcacTGG I L (563)
10 56a
Consensus for U2-type
GT-AG introns [21]
KAGgtragt yyyyyyncagG
Exon sequences are in capital letters, intron sequences are in lower case letters. The AT-AC splice site is in bold.
aThe length of the 5P and 3P UTRs in exon 1 and exon 10 is not included.
R. Wagener et al./FEBS Letters 438 (1998) 165^170166
Interestingly, we found in the human matrilin-4 gene an
AT-AG intron (C) between exon 3 and 4 that has not been
reported to be excised regularly [21]. In addition a GT-AT
transition of 5P splice donor sites is described in a number
of genetic disorders caused by skipping of the preceding
exon or the use of alternative splice sites leading to frameshift
mutations or loss of essential functional domains. To exclude
sequencing errors in the HTGS phase I sequence we ampli¢ed
the exon-intron border by PCR and con¢rmed the sequence
by direct sequencing of the PCR product (data not shown).
Additionally, using primer pairs m42/m416 and m414/415 we
determined the sequence of the corresponding part of the
mouse matrilin-4 gene from a genomic PCR product and
found the unmutated canonical GT splice donor site of U2-
type GT-AG introns (Fig. 2). In the human matrilin-4 gene
we identi¢ed a putative branch site sequence (CTGAC) 18
nucleotides upstream of the 3P splice site that ¢ts perfectly
to the consensus sequence for the putative branch site of
U2-type GT-AG introns (CTRAY) [21]. The 5P splice site
(ATGAGA) of intron C is homologous to the 5P splice site
of U2-type GT-AG introns (GTRAGT) and has no homology
with the 5P splice sites of U12-type AT-AC or U12-type GT-
AG introns [21], clearly indicating that the intron is a mutated
U2-type GT-AG intron.
3.2. Matrilin-4 cDNA
By RT-PCR we could detect expression of matrilin-4 in the
human embryonic kidney cell line HEK 293, adult lung, pla-
centa and WI-26 human ¢broblasts (Fig. 4), whereas we were
not able to detect expression on poly(A) Northern blots due
to a low expression level in the examined cells or tissues (not
shown). To date three human matrilin-4 EST sequences,
AA992948, AI038302 and H54037, have been published.
They are from total human foetuses, 8^9 weeks and 6 weeks
old, respectively. EST H54037 is characterised as a rarely
expressed cDNA and is mapped to q13.1^2 of chromosome
20 with in situ hybridisation using a radiolabelled probe
[25].
To determine the complete coding region of the human
matrilin-4 cDNA we performed RT-PCR with primers de-
signed from the putative exons on the genomic sequence.
RT-PCR products derived from the HEK 293 cell mRNA
were sequenced directly (Fig. 3). Only two di¡erences with
the exon sequences of HS453C12 were detected. In exon 2 a
silent substitution (A-G, nt 376, Fig. 3) and a single base
transversion (C-A, nt 518, Fig. 3) resulting in an arginine-
to-serine substitution are present only in HEK 293 cells and
placenta, whereas sequencing of the corresponding human
lung RT-PCR products con¢rmed the HTGS. The RT-PCR
resulted in three di¡erentially spliced human matrilin-4
cDNAs that were all di¡erent in the modular structure with
respect to the two di¡erentially spliced mouse transcripts (Fig.
5). All cDNAs contained the same sequences for the signal
peptide, the vWFA-like modules and the coiled-coil module,
but di¡ered in the number of EGF-like modules. Full-length
human matrilin-4 could be detected neither in HEK 293 cells
nor in lung, placenta and WI-26 human ¢broblasts where all
the other matrilin-4 RT-PCR products could be detected.
Mainly RT-PCR products containing EGF-like modules 2, 3
and 4 or products containing EGF-like modules 3 and 4 and
to a much lesser content containing only EGF-like module 4
were detected (Fig. 4A).
In the second splice variant the codons G671C672C673 of aa
215 (Ala) and G794C795C796 of aa 256 (Ala) are fused to a
resulting new GCC codon (Ala) leading to the transition nu-
cleotide sequence G671C795C796 and the corresponding amino
acid sequence C214A I257. In the shortest splice variant the
codons G671C672C673 of aa 215 (Ala) and G916T917C918 of aa
297 (Val) are fused to a resulting new GTC codon (Val) lead-
ing to the transition nucleotide sequence G671C917C918 and the
corresponding amino acid sequence C214V R298. Alternatively
spliced transcripts lacking the domain corresponding to
vWFA1 of mouse matrilin-4 [6] were not detected in human
matrilin-4. To unequivocally show the de¢ciency of the ¢rst
EGF-like module we performed genomic and RT-PCR on
HEK 293 cell mRNA with EGF1 module-speci¢c primers
and primers from the neighbouring vWFA1 and EGF4 mod-
ules in both directions. Only genomic PCR products but no
RT-PCR products could be detected (Fig. 4A,B), clearly in-
dicating that exon 3 is a pseudo-exon. While it encodes the
¢rst EGF-like domain, it is not retained in the mature
mRNA.
The overall identity to the mature mouse matrilin-4 is 91%
and the most conserved parts are the vWFA modules with an
identity of 92% for vWFA1 and 97% for vWFA2. The EGF-
like modules have an identity of 71% for the pseudo-EGF1
and 80%, 85% and 90% for EGF2, -3 and -4 respectively. The
identity of the coiled-coil domain is 87% but the heptad posi-
tions are perfectly conserved. The position and the spacing
between the cysteine residues and the MIDAS motif [26] are
identical in the mature proteins. The signal peptide of the
human matrilin-4 lacks two amino acids but the predicted
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Fig. 2. Comparison of exon 3 of human and mouse matrilin-4 and £anking intron sequences. Intron sequences are given in lower case, exon se-
quences in upper case letters. Mouse sequences are given in the upper line, human sequences in the lower line. For human only the amino acids
deviations are given. The length and the orientation of synthetic oligonucleotides used to prime the PCR are indicated by horizontal arrows.
The position of the corresponding mouse primers m42 (nt 685^702) for the m416/m42 PCR and m415 (nt 937^914) for m414/m415 PCR are
not given and can be derived from [6]. The numbering of the mouse exon sequence is according to [6]. The human splice acceptor site mutation
is indicated by a vertical arrow.
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signal peptide cleavage site [27] is identical in the human and
mouse matrilin-4. The three di¡erent splice variants yield ma-
ture protein products with predicted Mrs of 61 774, 57 255
and 52 784 respectively. Both N-glycosylation sites are con-
served in the human sequence (Asn69-Ala-Thr and Asn264-
His-Ser). A polyadenylation signal 296 bp downstream of
the stop codon could be identi¢ed on the genomic sequence
(Fig. 3).
4. Discussion
We have identi¢ed the human matrilin-4 gene on an HTGS
in the databases and with the sequence information we were
able to determine the primary structure by sequencing of RT-
PCR products. The overall high identity clearly demonstrated
that it is the human homologue of mouse matrilin-4. The
temporal and spatial expression pattern is also similar. Never-
FEBS 21050 9-11-98
Fig. 3. cDNA and deduced amino acid sequence of human matrilin-4. The deviations in the mouse matrilin-4 amino acid sequence are given
below. nt 1^19 and 2023^2080 are from HS453C12 and are given in lower case letters. The length and the orientation of synthetic oligonucleo-
tides used to prime the PCR are indicated by horizontal arrows. The potential signal peptide cleavage site is indicated by a vertical arrow. The
potential N-glycosylation sites are underlined with a dotted line, the polyadenylation signal with a solid line.
R. Wagener et al./FEBS Letters 438 (1998) 165^170168
theless the human matrilin-4 has striking di¡erences in mod-
ular composition of the di¡erent alternatively spliced gene
products (Fig. 5). The ¢rst EGF-like domain is not expressed
due to a GT-AT mutation in the 5P splice donor site of intron
C, although exon 3 encoding the ¢rst EGF is still present as a
pseudo-exon in the human matrilin-4 gene (Fig. 2). Pseudo-
exons are not unusual and can be found for example in hu-
man KA-crystallin [28] or rat aggrecan, where a heavily mu-
tated non-expressed EGF-like domain is present [29]. It is
interesting to see how substitution of one single nucleotide
in evolution can result in the loss of a protein module. The
homology to the corresponding expressed mouse matrilin-4
sequence is still 70% at the amino acid level, but clearly lower
than the identities of the expressed EGF-like domains, indi-
cating that the substitution occurred very recently in evolu-
tion.
A splice product lacking the ¢rst vWFA-like domain as
described in mouse matrilin-4 [6] has so far not been detected
in humans, but our access to human material from di¡erent
tissues and developmental stages has been limited. On the
other hand, we have not detected mouse matrilin-4 mRNA
lacking any of the EGF-like domains in a broad collection of
tissues at di¡erent developmental stages. It may be that this
di¡erence in alternative splice pattern is the e¡ect of the evo-
lutionary ¢ne tuning of the protein function in two di¡erent
mammalian species. As the EGF modules are believed to have
a spacing function alternative splicing will provide di¡erent
distances between the vWFA-like domains, which are likely
to carry important ligand binding sites.
The matrilin-4 gene, like the matrilin-1 gene [18^20], con-
tains a U12-type AT-AC intron that separates the two exons
encoding the coiled-coil domain. This is further strong evi-
dence for a common origin of the members of the matrilin
family in addition to the high structural homology of the
proteins. It is speculated that the removal of AT-AC introns
is rate-limiting for the maturation of their host mRNAs and
thereby contributes importantly to gene regulation [30]. It is
not unlikely that also the matrilin-2 and -3 genes contain a
U12-type AT-AC intron and the investigation of the matrilins
can lead to further insights into the function of this novel type
of spliceosome.
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